Chronic Bronchitis ' Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chronic Bronchitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chronic Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Bronchitis. Chronic Bronchitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Chronic Bronchitis.- A review of the Chronic Bronchitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.- Coverage of products based on various stages of development ranging from discovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.- Coverage of the Chronic Bronchitis pipeline on the basis of route of administration and molecule type.- Key discontinued pipeline projects.- Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Chronic Bronchitis.- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.- Devise corrective measures for pipeline projects by understanding Chronic Bronchitis pipeline depth and focus of Indication therapeutics.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Chronic Bronchitis ' Pipeline Review, H1 2013
Published on February 2013
Report Summary
Chronic Bronchitis ' Pipeline Review, H1 2013
Summary
Global Markets Direct's, 'Chronic Bronchitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
This report provides information on the therapeutic development for Chronic Bronchitis, complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic
Bronchitis. Chronic Bronchitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's
proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.
Scope
- A snapshot of the global therapeutic scenario for Chronic Bronchitis.
- A review of the Chronic Bronchitis products under development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chronic Bronchitis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Chronic Bronchitis.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive
advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Chronic Bronchitis pipeline depth and focus of Indication
therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table of Content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Chronic Bronchitis Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Chronic Bronchitis 7
Chronic Bronchitis Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
Chronic Bronchitis Therapeutics ' Products under Development by Companies 13
Companies Involved in Chronic Bronchitis Therapeutics Development 14
Rib-X Pharmaceuticals, Inc. 14
Nippon Shinyaku Co., Ltd. 15
Pharmaxis Ltd. 16
Yuhan Corporation 17
Probiomics Ltd. 18
NanoBio Corporation 19
CBio Limited 20
Beech Tree Labs, Inc. 21
Clarassance, Inc. 22
Chronic Bronchitis ' Therapeutics Assessment 23
Assessment by Monotherapy Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
delafloxacin - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
prulifloxacin - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
faropenem medoxomil - Drug Profile 33
Product Description 33
Mechanism of Action 33
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
R&D Progress 33
Drug For Respiratory Disease - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Drug For Chronic Bronchitis - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
YHD-001 - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
CG-459 - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
HI-164OV - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Chronic Bronchitis Therapeutics ' Drug Profile Updates 41
Chronic Bronchitis Therapeutics ' Discontinued Products 44
Chronic Bronchitis Therapeutics - Dormant Products 45
Chronic Bronchitis ' Product Development Milestones 46
Featured News & Press Releases 46
Jul 23, 2012: Forest Labs And Almirall Announce FDA Approval Of Tudorza Pressair For Long-Term Maintenance Treatment Of
COPD 46
Mar 02, 2012: Mylan Continues To Pursue Damages And Injunction Against Sunovion's Brovana In Ongoing Litigation 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 49
Disclaimer 49
List of Tables
Number of Products Under Development for Chronic Bronchitis, H1 2013 7
Products under Development for Chronic Bronchitis ' Comparative Analysis, H1 2013 8
Number of Products under Development by Companies, H1 2013 9
Comparative Analysis by Late Stage Development, H1 2013 10
Comparative Analysis by Mid Clinical Stage Development, H1 2013 11
Comparative Analysis by Pre-Clinical Stage Development, H1 2013 12
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Products under Development by Companies, H1 2013 13
Rib-X Pharmaceuticals, Inc., H1 2013 14
Nippon Shinyaku Co., Ltd., H1 2013 15
Pharmaxis Ltd., H1 2013 16
Yuhan Corporation, H1 2013 17
Probiomics Ltd., H1 2013 18
NanoBio Corporation, H1 2013 19
CBio Limited, H1 2013 20
Beech Tree Labs, Inc., H1 2013 21
Clarassance, Inc., H1 2013 22
Assessment by Monotherapy Products, H1 2013 23
Assessment by Stage and Route of Administration, H1 2013 25
Assessment by Stage and Molecule Type, H1 2013 27
Chronic Bronchitis Therapeutics ' Drug Profile Updates 41
Chronic Bronchitis Therapeutics ' Discontinued Products 44
Chronic Bronchitis Therapeutics ' Dormant Products 45
List of Figures
Number of Products under Development for Chronic Bronchitis, H1 2013 7
Products under Development for Chronic Bronchitis ' Comparative Analysis, H1 2013 8
Products under Development by Companies, H1 2013 9
Late Stage Products, H1 2013 10
Mid Clinical Stage Products, H1 2013 11
Pre-Clinical Stage Products, H1 2013 12
Assessment by Monotherapy Products, H1 2013 23
Assessment by Route of Administration, H1 2013 24
Assessment by Stage and Route of Administration, H1 2013 25
Assessment by Molecule Type, H1 2013 26
Assessment by Stage and Molecule Type, H1 2013 27
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Chronic Bronchitis ' Pipeline Review, H1 2013
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 000.00 Quantity: _____
Site License--USD 4 000.00 Quantity: _____
Corporate License--USD 6 000.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Chronic Bronchitis ' Pipeline Review, H1 2013 (From Slideshare) Page 6/6